• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Accenture, Salesforce Partner on Generative AI for Life Sciences Companies

Share:

November 14, 2023

Accenture and Salesforce are jointly investing in Salesforce Life Sciences Cloud, emphasizing AI and data-driven innovation. Their generative AI collaboration will utilize the joint acceleration hub to create solutions for Life Sciences Cloud. The initiative employs Salesforce Data Cloud and Einstein AI to enhance productivity and transform healthcare experiences. Accenture plans to develop tools and methodologies, enabling clients to test and pilot new capabilities within Salesforce Life Sciences Cloud, ultimately contributing to sustainable value and growth in the life sciences sector.

What You Should Know:

– Accenture and Salesforce are investing in the development of Salesforce Life Sciences Cloud, focusing on innovation, assets, and accelerators powered by data and artificial intelligence (AI) to help life sciences companies create sustainable value and drive growth.

– Building on their generative AI collaboration, Accenture and Salesforce will leverage their joint generative AI acceleration hub to develop new solutions and use cases for Salesforce Life Sciences Cloud.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Salesforce Data Cloud and Einstein AI

According to Accenture Research, 58% of life sciences companies consider the accelerated adoption of data and analytics capabilities as a top investment priority. As part of the collaboration, both will use Salesforce Data Cloud and Einstein AI, Salesforce’s AI technology, to enhance productivity and transform healthcare professional and patient experiences.

The patient services Health Cloud assessment framework generates insights and a value case for Salesforce Life Sciences Cloud. The pharmaceutical Data Cloud and Einstein AI accelerator leverages generative AI to provide a holistic view of provider and patient data and suggest the most important messages for patient interactions.

Future Development

Accenture will continue to develop complementary tools and methodologies to help clients test and pilot the new capabilities of Salesforce Life Sciences Cloud.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Mentice AB (STO: MNTC) Completes the Acquisition of ANKYRASMentice AB (STO: MNTC) Completes the Acquisition of ANKYRAS
  • European and U.s. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses By SartoriusEuropean and U.s. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses By Sartorius
  • Telehealth Firm mHS Launches Kickstarter Campaign for New Telehealth ProjectTelehealth Firm mHS Launches Kickstarter Campaign for New Telehealth Project
  • Thermavis launch thermal scanner after £3M investmentThermavis launch thermal scanner after £3M investment
  • Innovaccer Partners With Microsoft Teams to Launch Its Care Management SolutionInnovaccer Partners With Microsoft Teams to Launch Its Care Management Solution
  • Former Ro Director Launches Virtual Care Platform to Help Manage PCOSFormer Ro Director Launches Virtual Care Platform to Help Manage PCOS
  • Carepredict Launches New Tracing Tools in An Effort to Curb Coronavirus Spread in Nursing HomesCarepredict Launches New Tracing Tools in An Effort to Curb Coronavirus Spread in Nursing Homes
  • Google Cloud Expands Intelligent Vaccine Impact Solution to Support Vaccine EquityGoogle Cloud Expands Intelligent Vaccine Impact Solution to Support Vaccine Equity

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications